James Molloy
Stock Analyst at Alliance Global Partners
(0.34)
# 4,168
Out of 4,944 analysts
33
Total ratings
20.59%
Success rate
-40.43%
Average return
Main Sectors:
Stocks Rated by James Molloy
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SNGX Soligenix | Maintains: Buy | $10 → $6 | $2.45 | +144.90% | 1 | Jul 16, 2025 | |
IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.36 | +885.08% | 2 | Mar 6, 2025 | |
INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.29 | +2,831.03% | 1 | Jan 13, 2025 | |
VTVT vTv Therapeutics | Initiates: Buy | $35 | $14.03 | +149.47% | 1 | Dec 9, 2024 | |
GOVX GeoVax Labs | Initiates: Buy | $15 | $0.74 | +1,929.77% | 1 | Nov 11, 2024 | |
INMB INmune Bio | Initiates: Buy | $20 | $2.56 | +681.25% | 1 | Oct 21, 2024 | |
SCLX Scilex Holding Company | Initiates: Buy | $490 | $21.00 | +2,233.33% | 1 | Oct 16, 2024 | |
TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $61.57 | +1,686.58% | 7 | Jul 22, 2024 | |
PED PEDEVCO | Initiates: Buy | $1.75 | $0.62 | +182.94% | 1 | Jul 17, 2024 | |
PXS Pyxis Tankers | Initiates: Buy | $10 | $2.53 | +295.26% | 1 | Jul 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.88 | +1,490.91% | 2 | Jan 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.50 | +1,900.00% | 1 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.25 | +500.00% | 1 | Jul 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $6.56 | +204.88% | 1 | May 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.55 | +416.13% | 1 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $4.01 | +74.56% | 2 | Nov 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.97 | +8,145.72% | 1 | Nov 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.46 | +3,378.26% | 1 | Nov 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $4.72 | +5,832.20% | 1 | Oct 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $225 | $6.70 | +3,258.21% | 1 | Oct 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $7.18 | +116,891.64% | 1 | Sep 7, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $3.56 | +4,113.48% | 1 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.11 | +84,359.46% | 1 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.54 | +884.25% | 1 | Oct 4, 2021 |
Soligenix
Jul 16, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $2.45
Upside: +144.90%
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.36
Upside: +885.08%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.29
Upside: +2,831.03%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $14.03
Upside: +149.47%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.74
Upside: +1,929.77%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $2.56
Upside: +681.25%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $21.00
Upside: +2,233.33%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $61.57
Upside: +1,686.58%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.62
Upside: +182.94%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.53
Upside: +295.26%
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.88
Upside: +1,490.91%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.50
Upside: +1,900.00%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.25
Upside: +500.00%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $6.56
Upside: +204.88%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.55
Upside: +416.13%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $4.01
Upside: +74.56%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $0.97
Upside: +8,145.72%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.46
Upside: +3,378.26%
Oct 20, 2022
Initiates: Buy
Price Target: $280
Current: $4.72
Upside: +5,832.20%
Oct 13, 2022
Initiates: Buy
Price Target: $225
Current: $6.70
Upside: +3,258.21%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $7.18
Upside: +116,891.64%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $3.56
Upside: +4,113.48%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.11
Upside: +84,359.46%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.54
Upside: +884.25%